Lansoprazole sulfone N-oxide-d4, deuterium labeled Lansoprazole sulfone N-oxide

PD-1/PD-L1-IN-18 is a novel small molecule inhibitor of the PD-1/PD-L1 protein-protein interaction (IC50 of = 1.054 μM) with anticancer and immunomodulatory/immunoregulatory activity.

Hybutimibe, Ezetimibe analog and anti-hyperlipidemic drug

cis-Lomibuvir (cis-VX-222) is the cis-enantiomer of Lomibuvir (VX222; VCH-222), which is a selective, non-nucleoside polymerase inhibitor with antiviral activity. It acts by targeting thumb pocket 2 of the HCV NS5B polymerase (RdRp) with a Kd of 17 nM. Lomibuvir inhibits the 1b/Con1 HCV subgenomic replicon with an EC50 of 5.2 nM. Lomibuvir preferentially inhibits elongative […]

DPP-4-IN-2, DPP-4 (dipeptidyl peptidase 4) inhibitor

2-(3-Trifluoromethylphenyl)glycine HCl, dual V1a/V2 receptor antagonists

PD-1/PD-L1-IN-19 is a novel small molecule inhibitor of the PD-1/PD-L1 protein-protein interaction (IC50 of = 62 nM) with anticancer and immunomodulatory/immunoregulatory activity.

NSC-3852, HDAC (histone deacetylase) inhibitor.

DPP-4-IN-1, DPP-4 (dipeptidyl peptidase 4) inhibitor

Creatine D3 hydrate, tri-deuterated form of Creatine hydrate